Clinical trial
New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA): Sickle Cell Maculopathy
NCT03068702 is registered in ClinicalTrials.gov with Dr. S.S. Michel Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA): Sickle Cell Maculopathy
- Lead sponsor
- Dr. S.S. Michel Clinic
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 21, 2016
- Completion date
- February 21, 2017
- Enrollment
- 2 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell retinopathy